Dr. Christos Bergeles gave the honorary talk at the Greek Vitreoretinal Society Congress (http://gvrscongress.gr/en/) on 14th January 2017, titled "Advanced robotics for retinal micro-interventions and therapeutics delivery". The conference took place from 12th January 2017 to 14th January 2017, and several leading international ophthalmologists participated to discuss best clinical practices and new technological developments in vitreoretinal surgery.
The Institute of Neurology will be hosting their Inaugural lectures on Thursday 26th January 2017.
Professor Ying Li: Thursday 26th January, 5pm
Lecture Title: Repair CNS Injuries by Transplantation of Olfactory Ensheathing Cells
Professor Frederik Barkhof: Thursday 26th January, 6pm
Lecture Title: Translational Neuroimaging – from Engineering to Healthcare
The Translational Imaging Group, in collaboration with the Queen's Square Multiple Sclerosis Centre, recently published work in Brain on MTR ratio gradients
UCL has been selected as the 'hub' of the new £250m UK Dementia Research Institute (UK DRI), to be led by Professor Bart De Strooper, current leader of the Laboratory for the Research of Neurodegenerative Diseases at the University of Leuven.
Our research on Light-Field for Medical Imagigng, including Ophthalmoscopy, is featured at the "Innovators" issue of "The Ophthalmologist". The research, supported by Fight for Sight and Academy of Medical Sciences/Wellcome Trust, is led by Drs. Christos Bergeles (UCL) and Pearse Keane (Moorfields Eye Hospital). Please find the article here.
UCL has received over £13million from Wellcome and the Engineering and Physical Sciences Research Council (EPSRC) for a new surgical interventions centre led by the Institute of Healthcare Engineering.
The newly established Wellcome/EPSRC Centre for Surgical and Interventional Sciences at UCL will bring together a wide team of engineering and clinical experts working to develop new surgical technologies.
Dr. Bergeles from TIG visited a patient support group from Macular Society in the area of London to inform them on state of the art in robots for sight restoring therapies, receive feedback from the participants, and understand how this technology should be developed so that it is acceptable and accessible by the end users - patients. This story is featured in Sideview the newsletter of Macular Society, and you can find it here.